When you have a rare disease such as cold agglutinin disease (CAD), you need to be diligent to avoid infections. One common infection I have seen over and over being discussed is a urinary tract ...

COVID-19 infection may lead to autoimmunity by mimicking self ... who developed COVID-19-associated cold agglutinin syndrome (CAS), a condition that resembles cold agglutinin disease (CAD) but is ...

A 2018 phase II study of eculizumab in cold agglutinin disease (CAD) included 13 cases ... the patient developed complications, including a lung infection and osteoporosis. These were managed with ...

A rare case has been reported of diffuse large B-cell lymphoma (DLBCL) presenting initially as cold agglutinin disease (CAD). The report, published in the Kaohsiung Journal of Medical Sciences, ...

A sore throat is a common sign of a respiratory infection. A runny, stuffy nose can also indicate a cold, which is usually caused by a virus. However, sometimes, throat pain or other related ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...

In recent years, research has suggested a connection between oral bacteria and Alzheimer's disease, raising concerns for those with poor dental health. With nearly 700 species of bacteria ...

This suggested that an imbalance between these two bacteria might not just be a sign of disease, but could actually predict how severe it will be. We then examined whether this same imbalance ...

Get Instant Summarized Text (Gist) Broadleaf and ribwort plantain extracts have shown potential in inhibiting the growth of Borrelia burgdorferi, the bacteria responsible for Lyme disease. These ...

Scientists used advanced data analysis and machine learning to identify the viral proteins that may trigger autoimmune disorders such as type 1 diabetes and rheumatoid arthritis.

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.